This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
This provider hasn't verified their profile's information. Are you the owner of this center? Claim your listing to better manage your presence on Recovery.com.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Outpatient treatment offers flexible therapeutic and medical care without the need to stay overnight in a hospital or inpatient facility. Some centers off intensive outpatient program (IOP), which falls between inpatient care and traditional outpatient service.
Our admissions team will work with you to explore the right payment options based on your needs, ensuring you get the best possible treatment.
AppleGate Recovery, part of BayMark Health Services, provides outpatient medication-assisted treatment (MAT) for individuals struggling with opioid addiction. Their programs use FDA-approved buprenorphine-based medications, such as Suboxone, to help manage withdrawal symptoms and reduce cravings. This evidence-based approach allows patients to recover while maintaining daily responsibilities, offering a flexible and confidential path to lasting recovery.
Their centers combine MAT with professional substance use counseling to address both the physical and emotional aspects of addiction. Patients receive individual and group therapy sessions, where they learn coping skills, relapse prevention strategies, and ways to rebuild relationships. If on-site counseling isn't available, AppleGate Recovery ensures patients are connected to trusted external providers for support.
AppleGate Recovery focuses on patient-centered care, offering telemedicine options for existing patients, flexible scheduling, and the ability to fill prescriptions at local pharmacies. Their compassionate team provides a judgment-free environment where patients can work toward their goals. With multiple locations and a commitment to individualized treatment, they make recovery more accessible for those in need.
This center primarily treats substance use disorders, helping you stabilize, create relapse-prevention plans, and connect to compassionate support.
Medication-Assisted Treatment (MAT) is an evidence-based approach that pairs FDA-approved medications with counseling to treat addiction. The medications are used to reduce cravings, ease withdrawal symptoms, or block the effects of substances. More about MAT
Dolophine®, Methadose®
Methadone is a full opioid agonist, meaning it activates opioid receptors in the brain to produce effects like pain relief and euphoria. It is longer acting than many other opioids, making it useful in medication-assisted treatment for opioid use disorder.
It reduces withdrawal symptoms and cravings by occupying opioid receptors without causing intense highs. Because it is a full agonist, it must be used carefully to avoid overdose, but it is highly effective when taken as prescribed within a structured program.
Vivitrol®, Revia®
Naltrexone is an opioid antagonist, meaning it blocks opioid receptors in the brain and prevents opioids from producing effects like euphoria or sedation. It is used to treat both opioid and alcohol use disorders, but does not cause physical dependence or withdrawal.
It helps reduce cravings and the rewarding effects of opioids or alcohol, supporting long-term recovery. Because it blocks opioid effects, it should only be started after a person has fully detoxed from opioids to avoid triggering withdrawal.
Suboxone®, Subutex®, Sublocade®, Zubsolv®
Buprenorphine is a partial opioid agonist used to treat opioid use disorder. It activates opioid receptors to reduce cravings and withdrawal but has a ceiling effect, meaning it produces less euphoria and respiratory depression than full opioids.
Buprenorphine binds tightly to opioid receptors, blocking other opioids from attaching and reducing the risk of misuse. It's often combined with naloxone (as in Suboxone®) to discourage injection misuse and is available in daily or monthly forms.